By Jill Stein Special to DG News NEW YORK, NY — May 16, 2002 —
The fixed-dose combination of amlodipine/benazepril decreases blood pressure earlier and to a greater extent than the angiotensin-converting enzyme (ACE) inhibitor enalapril given alone in patients with hypertension and type 2 diabetes, researchers reported at the 17th Annual Scientific Meeting of the American Society of Hypertension (ASH).
The results also show that amlodipine/benazepril achieved its effect with no sacrifice in renal protection caused by the addition of the calcium channel blocker. Dr. George Bakris, of Rush Presbyterian/St. Luke’s Medical Center in Chicago, Illinois, and associates randomised 214 patients to enalapril (10 mg titrated to 20 mg) or the fixed dose combination of amlodipine/benazepril (5 mg/10 mg titrated to 5 mg/20 mg). Hydrochlorothiazide, 12.5 mg, was added if patients had not reached their target blood pressure level at eight weeks.
The primary end point was the time to goal of blood pressure less than 130/85 mm Hg. The study found that subjects taking the fixed-dose combination of amlodipine/benazepril achieved their target blood pressure significantly faster than did subjects who received ACE inhibitor monotherapy (5.3 weeks versus 6.4 weeks, respectively).
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!